Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells

  1. Melissa T Adams
  2. JaeAnn M Dwulet
  3. Jennifer K Briggs
  4. Christopher A Reissaus
  5. Erli Jin
  6. Joseph M Szulczewski
  7. Melissa R Lyman
  8. Sophia M Sdao
  9. Vira Kravets
  10. Sutichot D Nimkulrat
  11. Suzanne M Ponik
  12. Matthew J Merrins
  13. Raghavendra G Mirmira
  14. Amelia K Linnemann
  15. Richard KP Benninger
  16. Barak Blum  Is a corresponding author
  1. University of Wisconsin-Madison, United States
  2. University of Colorado Denver, Anschutz Medical Campus, United States
  3. Indiana University School of Medicine, United States
  4. University of Colorado-Denver, United States
  5. University of Chicago, United States

Abstract

The spatial architecture of the islets of Langerhans is hypothesized to facilitate synchronized insulin secretion among β cells yet testing this in vivo in the intact pancreas is challenging. Robo βKO mice, in which the genes Robo1 and Robo2 are deleted selectively in β cells, provide a unique model of altered islet spatial architecture without loss of β cell differentiation or islet damage from diabetes. Combining Robo βKO mice with intravital microscopy, we show here that Robo βKO islets have reduced synchronized intra-islet Ca2+ oscillations among β cells in vivo. We provide evidence that this loss is not due to a β cell-intrinsic function of Robo, mis-expression or mis-localization of Cx36 gap junctions, or changes in islet vascularization or innervation, suggesting that the islet architecture itself is required for synchronized Ca2+ oscillations. These results have implications for understanding structure-function relationships in the islets during progression to diabetes as well as engineering islets from stem cells.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Melissa T Adams

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. JaeAnn M Dwulet

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2519-5193
  3. Jennifer K Briggs

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christopher A Reissaus

    Herman B Wells Center for Pediatric Research and Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Erli Jin

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Joseph M Szulczewski

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Melissa R Lyman

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0091-0413
  8. Sophia M Sdao

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Vira Kravets

    Bioengineering, University of Colorado-Denver, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5147-309X
  10. Sutichot D Nimkulrat

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Suzanne M Ponik

    Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Matthew J Merrins

    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Raghavendra G Mirmira

    Kovler Diabetes Center and the Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Amelia K Linnemann

    Herman B Wells Center for Pediatric Research and Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Richard KP Benninger

    Department of Bioengineering and Barbara Davis Center for Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5063-6096
  16. Barak Blum

    Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, United States
    For correspondence
    bblum4@wisc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5308-4194

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121706)

  • Barak Blum

American Diabetes Association (ADA 1-16-IBS-212)

  • Matthew J Merrins

National Institute of General Medical Sciences (5T32GM007133-44)

  • Melissa T Adams

National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020579)

  • Barak Blum

UW-Madison Institute for Clinical and Translational Research (UL1TR000427)

  • Matthew J Merrins
  • Barak Blum

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060581)

  • Raghavendra G Mirmira

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102950)

  • Richard KP Benninger

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106412)

  • Richard KP Benninger

National Cancer Institute (R01CA216248)

  • Suzanne M Ponik

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK113103)

  • Matthew J Merrins

National Institute on Aging (R01AG062328)

  • Matthew J Merrins

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The experimental protocol for animal usage was reviewed and approved by the University of Wisconsin-Madison Institutional Animal Care and Use Committee (IACUC) under Protocol #M005221 and Protocol #M005333, and all animal experiments were conducted in accordance with the University of Wisconsin-Madison IACUC guidelines under the approved protocol.

Copyright

© 2021, Adams et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,227
    views
  • 235
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Melissa T Adams
  2. JaeAnn M Dwulet
  3. Jennifer K Briggs
  4. Christopher A Reissaus
  5. Erli Jin
  6. Joseph M Szulczewski
  7. Melissa R Lyman
  8. Sophia M Sdao
  9. Vira Kravets
  10. Sutichot D Nimkulrat
  11. Suzanne M Ponik
  12. Matthew J Merrins
  13. Raghavendra G Mirmira
  14. Amelia K Linnemann
  15. Richard KP Benninger
  16. Barak Blum
(2021)
Reduced synchroneity of intra-islet Ca2+ oscillations in vivo in Robo-deficient β cells
eLife 10:e61308.
https://doi.org/10.7554/eLife.61308

Share this article

https://doi.org/10.7554/eLife.61308

Further reading

    1. Cell Biology
    Chenlu Kang, Pengcheng Chen ... Congying Wu
    Research Article

    Cell migration towards stiff substrates has been coined as durotaxis and implicated in development, wound healing, and cancer, where complex interplays between immune and non-immune cells are present. Compared to the emerging mechanisms underlying the strongly adhesive mesenchymal durotaxis, little is known about whether immune cells - migrating in amoeboid mode - could follow mechanical cues. Here, we develop an imaging-based confined migration device with a stiffness gradient. By tracking live cell trajectory and analyzing the directionality of T cells and neutrophils, we observe that amoeboid cells can durotax. We further delineate the underlying mechanism to involve non-muscle myosin IIA (NMIIA) polarization towards the soft-matrix-side but may not require differential actin flow up- or down-stiffness gradient. Using the protista Dictyostelium, we demonstrate the evolutionary conservation of amoeboid durotaxis. Finally, these experimental phenomena are theoretically captured by an active gel model capable of mechanosensing. Collectively, these results may shed new lights on immune surveillance and recently identified confined migration of cancer cells, within the mechanically inhomogeneous tumor microenvironment or the inflamed fibrotic tissues.

    1. Cell Biology
    2. Developmental Biology
    Yi Sun, Zhe Chen ... Chengtian Zhao
    Short Report

    How cells regulate the size of their organelles remains a fundamental question in cell biology. Cilia, with their simple structure and surface localization, provide an ideal model for investigating organelle size control. However, most studies on cilia length regulation are primarily performed on several single-celled organisms. In contrast, the mechanism of length regulation in cilia across diverse cell types within multicellular organisms remains a mystery. Similar to humans, zebrafish contain diverse types of cilia with variable lengths. Taking advantage of the transparency of zebrafish embryos, we conducted a comprehensive investigation into intraflagellar transport (IFT), an essential process for ciliogenesis. By generating a transgenic line carrying Ift88-GFP transgene, we observed IFT in multiple types of cilia with varying lengths. Remarkably, cilia exhibited variable IFT speeds in different cell types, with longer cilia exhibiting faster IFT speeds. This increased IFT speed in longer cilia is likely not due to changes in common factors that regulate IFT, such as motor selection, BBSome proteins, or tubulin modification. Interestingly, longer cilia in the ear cristae tend to form larger IFT compared to shorter spinal cord cilia. Reducing the size of IFT particles by knocking down Ift88 slowed IFT speed and resulted in the formation of shorter cilia. Our study proposes an intriguing model of cilia length regulation via controlling IFT speed through the modulation of the size of the IFT complex. This discovery may provide further insights into our understanding of how organelle size is regulated in higher vertebrates.